Black Swan Analysis Overview
- Founded
- 2007
- Status
- Acquired/Merged
- Employees
- 20
- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 1
Black Swan Analysis General Information
Description
Operator of a consultancy firm specializing in asset valuations and epidemiology based in London, United Kingdom. The company provides analysis, modelling and market forecasting, valuations, commercialization plans, lifecycle optimization solutions and strategic insight to companies in the healthcare industry, with a focus on bespoke epidemiology and segmentation serving top pharmaceutical companies, biotech and tech transfer offices.
Contact Information
Website
www.blackswan-analysis.co.uk
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Acquirer
Primary Office
- The Place
- Bridge Avenue
- Maidenhead SL6 1AF
- England, United Kingdom
+44 01628 000000
Black Swan Analysis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Black Swan Analysis‘s full profile, request access.
Request a free trialBlack Swan Analysis Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Nic Talbot-Watt | Chief Executive Officer, Managing Director, Director of Analysis and Forecasting and Founder |
Black Swan Analysis Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial